Insights

Strategic Partnerships Eurofins CDMO Europe actively engages in strategic collaborations with industry leaders like TRI Princeton, CMP Scientific, and Daresbury Proteins to enhance capabilities in clinical testing, biopharmaceutical characterization, and advanced ADC production. These partnerships illustrate opportunities to offer integrated services or complementary testing solutions to clients involved in innovative drug development.

Facility Expansion The company is investing significantly in expanding its manufacturing and testing infrastructure, including a new 300,000-square-foot biopharma testing facility in Leola, Pennsylvania, expected to create 250 new jobs. This expansion signals ongoing capacity growth, which can open up sales opportunities for advanced manufacturing, analytical testing, and logistical services.

Technological Advancements Eurofins utilizes cutting-edge technologies such as CE-MS, Chem-ST for toys, and GMP PFAS testing, positioning itself as a provider of innovative testing solutions. Targeting clients requiring state-of-the-art analytical and safety testing can be a lucrative avenue for customized and high-value service offerings.

Regulatory Expertise With accreditation from major regulatory agencies like FDA, EMA, and Health Canada, Eurofins emphasizes its compliance and quality standards, making it an appealing partner for clients navigating complex regulatory landscapes. There is potential to expand services related to regulatory support, CMC RA, and quality assurance for emerging biopharma companies.

Market Focus Operating across diverse therapeutic areas including immunotherapies, orphan drugs, and pediatric formulations, Eurofins has a broad market scope. Identifying clients developing innovative or difficult-to-formulate drugs presents sales opportunities for customized development, formulation, and testing services tailored to their unique needs.

Eurofins CDMO Europe Tech Stack

Eurofins CDMO Europe uses 8 technology products and services including Octopus Deploy, Microsoft Dynamics, React Redux, and more. Explore Eurofins CDMO Europe's tech stack below.

  • Octopus Deploy
    Deployment
  • Microsoft Dynamics
    Enterprise Resource Planning
  • React Redux
    Javascript Frameworks
  • BEM
    Javascript Frameworks
  • Cisco Meraki
    Network Hardware
  • Coupa Procurement
    Procurement
  • LabVIEW
    Visualisation Software
  • GoTo Meeting
    Web Conferencing

Media & News

Eurofins CDMO Europe's Email Address Formats

Eurofins CDMO Europe uses at least 2 format(s):
Eurofins CDMO Europe Email FormatsExamplePercentage
First.Last@amatsigroup.comJohn.Doe@amatsigroup.com
53%
F.Last@amatsigroup.comJ.Doe@amatsigroup.com
31%
First@amatsigroup.comJohn@amatsigroup.com
10%
FirstLast@amatsigroup.comJohnDoe@amatsigroup.com
4%
Last@amatsigroup.comDoe@amatsigroup.com
2%
FirstLast@eurofins.comJohnDoe@eurofins.com
93%
FirLast@eurofins.comJohDoe@eurofins.com
3%
FirstMiddleLast@eurofins.comJohnMichaelDoe@eurofins.com
2%
FirstLas@eurofins.comJohnDoe@eurofins.com
2%

Frequently Asked Questions

Where is Eurofins CDMO Europe's headquarters located?

Minus sign iconPlus sign icon
Eurofins CDMO Europe's main headquarters is located at 2 Bis Avenue de Gascogne Fontenilles, Occitanie 31470 France. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Eurofins CDMO Europe's phone number?

Minus sign iconPlus sign icon
You can contact Eurofins CDMO Europe's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eurofins CDMO Europe's official website and social media links?

Minus sign iconPlus sign icon
Eurofins CDMO Europe's official website is eurofins.com and has social profiles on LinkedIn.

What is Eurofins CDMO Europe's SIC code NAICS code?

Minus sign iconPlus sign icon
Eurofins CDMO Europe's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Eurofins CDMO Europe have currently?

Minus sign iconPlus sign icon
As of March 2026, Eurofins CDMO Europe has approximately 395 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Group Cfo: D. V.Director Drug Substance & Drug Product Manufacturing: D. A.Managing Director: Y. G.. Explore Eurofins CDMO Europe's employee directory with LeadIQ.

What industry does Eurofins CDMO Europe belong to?

Minus sign iconPlus sign icon
Eurofins CDMO Europe operates in the Pharmaceutical Manufacturing industry.

What technology does Eurofins CDMO Europe use?

Minus sign iconPlus sign icon
Eurofins CDMO Europe's tech stack includes Octopus DeployMicrosoft DynamicsReact ReduxBEMCisco MerakiCoupa ProcurementLabVIEWGoTo Meeting.

What is Eurofins CDMO Europe's email format?

Minus sign iconPlus sign icon
Eurofins CDMO Europe's email format typically follows the pattern of First.Last@amatsigroup.com. Find more Eurofins CDMO Europe email formats with LeadIQ.

When was Eurofins CDMO Europe founded?

Minus sign iconPlus sign icon
Eurofins CDMO Europe was founded in 2010.

Eurofins CDMO Europe

Pharmaceutical ManufacturingOccitanie, France201-500 Employees

Eurofins CDMO is a leading global Contract Development and Manufacturing Organization (CDMO) that provides clients with APIs / Drug Substance and Drug Product development for biologicals and small molecules. Science is our fondation and allows us to support small and major biopharmaceutical companies. Our sustainable and flexible methods help them achieve their pre-clinical and clinical milestones on time.

We are experts in breakthrough technologies for API development, highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms, etc.)

Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations. Frequent communication through one single point of contact, our team's flexibility, troubleshooting mindset, customized solutions will help speed up the drug development process. Operating under strict quality procedures, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada.

Our goal is to build a sustainable partnership with our customers to support their drug development pathway.

Our service offerings include:
- Drug Substance/API development
- Solid State Research & Development
- Pre-Formulation, Formulation Development
- Analytical Development
- GMP Manufacturing
- Clinical packaging and logistics
- Project management
- CMC RA

Choose Eurofins CDMO to help you:
- Move rapidly through the drug development value chain (API/DS and DP)
- Perform complex formulation screening and development
- Accelerate process development and scale-up under GMP compliance
- Achieve clinical & small commercial manufacturing batches (Sterile and Non Sterile)
- Provide clinical trial material including packaging and logistics
- Ensure regulatory compliance throughout each stage of the development cycle with full CMC-RA support

Section iconCompany Overview

Headquarters
2 Bis Avenue de Gascogne Fontenilles, Occitanie 31470 France
Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Eurofins CDMO Europe's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Eurofins CDMO Europe's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.